180 related articles for article (PubMed ID: 36757183)
1. Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
Syed RR; Catanzaro DG; Colman RE; Cooney CG; Linger Y; Kukhtin AV; Holmberg RC; Norville R; Crudu V; Ciobanu N; Codreanu A; Seifert M; Hillery N; Chiles P; Catanzaro A; Rodwell TC
J Clin Microbiol; 2023 Mar; 61(3):e0147822. PubMed ID: 36757183
[TBL] [Abstract][Full Text] [Related]
2. Laboratory Evaluation of a Lateral-Flow Cell for Molecular Detection of First-Line and Second-Line Antituberculosis Drug Resistance.
Catanzaro DG; Colman RE; Linger Y; Georghiou SB; Kukhtin AV; Seifert M; Holmberg RC; Mshaiel H; Chiles P; Hillery N; Cooney CG; Rodwell TC
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32817085
[TBL] [Abstract][Full Text] [Related]
3. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.
Penn-Nicholson A; Georghiou SB; Ciobanu N; Kazi M; Bhalla M; David A; Conradie F; Ruhwald M; Crudu V; Rodrigues C; Myneedu VP; Scott L; Denkinger CM; Schumacher SG;
Lancet Infect Dis; 2022 Feb; 22(2):242-249. PubMed ID: 34627496
[TBL] [Abstract][Full Text] [Related]
4. [Exploratory study on detection of drug resistance of
Liu YY; Shi J; Chu P; Wu TY; Li L; Pang Y; Lu J; Guo YL
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):552-559. PubMed ID: 35658379
[No Abstract] [Full Text] [Related]
5. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
6. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
[TBL] [Abstract][Full Text] [Related]
7. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
8. Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
Dymova MA; Cherednichenko AG; Alkhovik OI; Khrapov EA; Petrenko TI; Filipenko ML
BMC Infect Dis; 2014 Sep; 14():478. PubMed ID: 25186134
[TBL] [Abstract][Full Text] [Related]
9. Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Khanna A; Raj VS; Tarai B; Sood R; Pareek PK; Upadhyay DJ; Sharma P; Rattan A; Saini KS; Singh H
Antimicrob Agents Chemother; 2010 Nov; 54(11):4789-93. PubMed ID: 20713679
[TBL] [Abstract][Full Text] [Related]
10. Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.
Chakravorty S; Roh SS; Glass J; Smith LE; Simmons AM; Lund K; Lokhov S; Liu X; Xu P; Zhang G; Via LE; Shen Q; Ruan X; Yuan X; Zhu HZ; Viazovkina E; Shenai S; Rowneki M; Lee JS; Barry CE; Gao Q; Persing D; Kwiatkawoski R; Jones M; Gall A; Alland D
J Clin Microbiol; 2017 Jan; 55(1):183-198. PubMed ID: 27807153
[TBL] [Abstract][Full Text] [Related]
11. Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.
Rodwell TC; Valafar F; Douglas J; Qian L; Garfein RS; Chawla A; Torres J; Zadorozhny V; Kim MS; Hoshide M; Catanzaro D; Jackson L; Lin G; Desmond E; Rodrigues C; Eisenach K; Victor TC; Ismail N; Crudu V; Gler MT; Catanzaro A
J Clin Microbiol; 2014 Mar; 52(3):781-9. PubMed ID: 24353002
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.
Ajbani K; Lin SY; Rodrigues C; Nguyen D; Arroyo F; Kaping J; Jackson L; Garfein RS; Catanzaro D; Eisenach K; Victor TC; Crudu V; Gler MT; Ismail N; Desmond E; Catanzaro A; Rodwell TC
Antimicrob Agents Chemother; 2015 Jan; 59(1):414-20. PubMed ID: 25367911
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.
Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
BMC Microbiol; 2014 Jun; 14():165. PubMed ID: 24953243
[TBL] [Abstract][Full Text] [Related]
16. Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.
Georghiou SB; Seifert M; Catanzaro D; Garfein RS; Valafar F; Crudu V; Rodrigues C; Victor TC; Catanzaro A; Rodwell TC
Antimicrob Agents Chemother; 2016 Jul; 60(7):3994-4004. PubMed ID: 27090176
[TBL] [Abstract][Full Text] [Related]
17. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
[TBL] [Abstract][Full Text] [Related]
18. Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
Safari M; Moghim S; Salehi M; Jafari R; Nasr Esfahani B
Infect Genet Evol; 2020 Nov; 85():104468. PubMed ID: 32711076
[TBL] [Abstract][Full Text] [Related]
19. RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea.
Oh TS; Kim YJ; Kang HY; Kim CK; Cho SY; Lee HJ
Infect Genet Evol; 2017 Apr; 49():111-115. PubMed ID: 28062386
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis.
Mao X; Ke Z; Shi X; Liu S; Tang B; Wang J; Huang H
Ann Clin Lab Sci; 2015; 45(5):533-44. PubMed ID: 26586705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
